| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |